Labcorp is Set to Acquire Select Assets of BioReference Health of OPK
LH inks new agreement to acquire BioReference Health's oncology and related clinical testing services businesses.
Labcorp to buy Opko unit’s cancer test assets for up to $225M
Labcorp will acquire the oncology diagnostics operations from BioReference Health as part of a push to expand in high-growth testing areas.
Labcorp to acquire select oncology testing assets for up to $225M
The independent laboratory company has entered an agreement to acquire BioReference Health's oncology diagnostic services.
Labcorp to Buy Some OPKO BioReference Assets for Up to $225 Million
Labcorp Holdings has signed a deal to buy certain assets of OPKO Health's BioReference Health unit for up to $225 million. Labcorp on Tuesday said it will pay $192.5 million at closing for BioReference's laboratory testing businesses, which is focused on oncology and oncology-related clinical testing services across the U.S.
Labcorp to acquire certain assets of Opko Health’s BioReference Health
Labcorp (LH) and OPKO Health (OPK) announced earlier on Tuesday that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health.
Labcorp to acquire select assets of BioReference Health's innovative oncology and related clinical testing services businesses
Burlington, North Carolina Wednesday, March 12, 2025, 14:00 Hrs [IST]
Labcorp Acquiring BioReference Health Oncology Testing Assets for $225M
The deal is part of BioReference's ongoing effort to streamline its business to achieve profitability and follows the sale last year of clinical laboratory assets to Labcorp.
Labcorp to Acquire Select Assets of BioReference Health
Labcorp has entered into an agreement to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health.
Opko Health to sell more assets to Labcorp for $225 million
The sale comes after the Miami company agreed to pay $704,349 to settle allegations that it billed the federal government for unnecessary blood tests.
Hosted on MSN1mon
BioReference faces $704,349 fine for medically unnecessary blood tests
BioReference Health LLC, formerly known as BioReference Laboratories Inc. (BioReference) and OPKO Health Inc. (OPKO), face a $704,349 government fine for medically unnecessary blood tests.
Labcorp, Opko Health acquire certain assets of BioReference Health
Labcorp (LH) and OPKO Health (OPK) announced that they have entered into an agreement for Labcorp to acquire select assets of BioReference ...
Truist remains bullish on Labcorp after ‘another nice strategic acquisition’
Truist analyst David MacDonald notes Labcorp (LH) announced that the company has reached an agreement to acquire oncology-focused lab testing assets from BioReference Health (OPK) for $192.5M, with an ...